GlassScriptPhysician profile
Dallin B Gambles
NPI 1760533400
$10,239.85
in general payments reported to CMS, 2019-2025
73 companies · $2,752 in 2025
The $2,752 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,453 · 2022: $1,862 · 2023: $1,971 · 2024: $2,202 · 2025: $2,752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,745 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,745.00 |
| Education | $179.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $792.54 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $597.16 | 2021-2025 | Lynparza, Imfinzi, Enhertu |
| Genzyme Corporation | $587.23 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $568.13 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $523.02 | 2021-2025 | |
| Daiichi Sankyo INC. | $445.93 | 2021-2025 | Enhertu, Injectafer |
| Genentech USA, INC. | $427.62 | 2021-2025 | Venclexta, Gazyva, Phesgo |
| Janssen Biotech, INC. | $405.26 | 2021-2025 | Carvykti, Erleada, Balversa |
| E.R. Squibb & Sons, L.L.C. | $337.57 | 2021-2025 | Opdivo |
| Astellas Pharma US INC | $324.86 | 2021-2025 | Xtandi, Padcev |
| Amgen INC. | $306.32 | 2021-2023 | Lumakras, Xgeva, Nplate |
| Seagen INC. | $302.72 | 2021-2023 | Padcev, Adcetris |
| Pharmacyclics LLC, An Abbvie Company | $254.31 | 2021-2023 | Imbruvica |
| Lilly USA, LLC | $253.06 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Abbvie INC. | $251.58 | 2022-2025 |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $216.91 | 2021-2025 | Trodelvy |
| Celgene Corporation | $203.85 | 2021-2025 | Reblozyl |
| Eisai INC. | $202.21 | 2021-2023 | |
| Blueprint Medicines Corporation | $185.87 | 2022-2025 | Ayvakit |
| Aveo Pharmaceuticals, INC. | $152.43 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $146.91 | 2023-2024 | Fruzaqla, Iclusig |
| Incyte Corporation | $142.98 | 2021-2025 | Monjuvi, Jakafi, Niktimvo |
| Tersera Therapeutics LLC | $139.06 | 2022-2025 | Zoladex |
| Jazz Pharmaceuticals INC. | $136.47 | 2021-2025 | |
| Sobi, INC | $131.16 | 2022-2025 | |
| Glaxosmithkline, LLC. | $107.47 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Emd Serono, INC. | $107.40 | 2021-2024 | Tepmetko, Bavencio |
| Alexion Pharmaceuticals, INC. | $107.09 | 2022-2025 | Koselugo |
| Rigel Pharmaceuticals, INC. | $97.40 | 2023-2025 | Rezlidhia, Tavalisse, Gavreto |
| Sumitomo Pharma America, INC. | $92.18 | 2023-2025 | Orgovyx |
| Puma Biotechnology, INC. | $89.70 | 2023-2025 | |
| Coherus Oncology, INC. | $88.69 | 2022-2024 | |
| Genmab U.S., INC. | $78.72 | 2023-2025 | Epkinly |
| Deciphera Pharmaceuticals INC. | $77.24 | 2021-2023 | Qinlock |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.83 | 2021-2024 | Gilotrif |
| Spectrum Pharmaceuticals INC. | $60.02 | 2023-2025 | Rolvedon |
| Myovant Sciences INC. | $59.34 | 2022 | |
| Stemline Therapeutics INC. | $58.17 | 2023-2024 | Orserdu |
| Beone Medicines USA, INC. | $56.96 | 2025 | Brukinsa |
| Medtronic, INC. | $56.44 | 2021 | |
| Springworks Therapeutics, INC. | $54.47 | 2024-2025 | Ogsiveo |
| Azurity Pharmaceuticals, INC. | $48.48 | 2024-2025 | Danziten, Vivimusta |
| Pharmaessentia USA Corporation | $47.72 | 2025 | Besremi |
| Kite Pharma, INC. | $47.46 | 2022-2023 | |
| Taiho Oncology, INC. | $43.67 | 2024 | |
| Csl Behring | $42.60 | 2021-2025 | Hemgenix |
| Adc Therapeutics America, INC. | $41.23 | 2025 | |
| Beigene USA, INC. | $40.50 | 2022-2024 | Brukinsa |
| Fennec Pharmaceuticals, INC. | $40.47 | 2023-2024 | Pedmark |
| Geron Corporation | $40.19 | 2025 | Rytelo |
| Adaptive Biotechnologies Corporation | $40.08 | 2023-2025 | Clonoseq |
| Pharmacosmos Therapeutics INC. | $37.30 | 2024-2025 | Monoferric |
| Regeneron Healthcare Solutions, INC. | $36.32 | 2023-2024 | Libtayo |
| Dendreon Pharmaceuticals LLC | $34.74 | 2025 | Provenge |
| Exelixis INC. | $30.19 | 2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $29.99 | 2021-2024 | Onivyde, Somatuline Depot |
| Immunocore Limited | $29.71 | 2025 | Kimmtrak |
| Array Biopharma INC | $28.59 | 2025 | Mektovi, Xalkori, Lorbrena |
| Bayer Healthcare Pharmaceuticals INC. | $24.16 | 2024 | |
| Iovance Biotherapeutics, INC. | $22.36 | 2025 | Amtagvi |
| Cycle Pharmaceuticals INC | $22.13 | 2025 | Phyrago |
| Abbott Laboratories | $21.84 | 2025 | Eterna |
| Nuvation Bio INC. | $19.98 | 2025 | Ibtrozi |
| Servier Pharmaceuticals LLC | $19.36 | 2024 | |
| Acrotech Biopharma INC. | $19.21 | 2021 | |
| Morphosys, US INC. | $18.77 | 2023 | Monjuvi |
| Apellis Pharmaceuticals, INC. | $17.66 | 2022 | |
| Siemens Medical Solutions USA, INC. | $16.67 | 2021 | |
| Eusa Pharma (US) LLC | $16.34 | 2021 | |
| Epizyme, INC. | $16.08 | 2021 | |
| Karyopharm Therapeutics INC. | $15.57 | 2021 | |
| Fresenius Kabi USA, LLC | $14.99 | 2025 | Stimufend |
| Alnylam Pharmaceuticals INC. | $14.21 | 2024 | Amvuttra |
Drugs and devices associated with these payments
Keytruda $423Xtandi $322Enhertu $293Sarclisa $235Orgovyx $210Lynparza $197Venclexta $191Ayvakit $190Welireg $180Opdivo $179Trodelvy $169Talzenna $162Adcetris $148Kisqali $143Jaypirca $143Verzenio $143Imbruvica $136Inlyta $132Carvykti $128Zoladex $125Ibrance $125Elrexfio $125Fotivda $117Vonjo $117Padcev $116Epkinly $116Injectafer $113Gazyva $113Tavalisse $97.40Rezlidhia $97.40Reblozyl $95.86Erleada $95.77Fruzaqla $93.71Tukysa $93.63Zepzelca $93.39Imfinzi $84.87Koselugo $84.19Brukinsa $81.53Elitek $78.66Cablivi $76.27Enjaymo $76.27Cerdelga $68.81Phesgo $64.13Bosulif $62.46Paxlovid $61.92Balversa $61.20Rolvedon $60.02Orserdu $58.17Fabhalta $57.24Rozlytrek $54.90Tecentriq $54.90Alecensa $54.90Darzalex $54.76Ogsiveo $54.47Udenyca $53.85Keytruda Qlex $53.64Iclusig $53.20Ojjaara $52.19Monjuvi $51.28Lorbrena $49.14Tivdak $48.43Retevmo $47.88Besremi $47.72Comirnaty $47.34Pluvicto $45.32Inqovi $43.67Lonsurf $43.67Akeega $43.33Zynlonta $41.23Rituxan $40.52Pedmark $40.47Rytelo $40.19Clonoseq $40.08Lupron Depot $39.79Bavencio $39.25Gavreto $38.68Lenvima $38.26Monoferric $37.30Perjeta $36.63Libtayo $36.32Provenge $34.74Lumakras $34.66Nplate $32.57Xgeva $32.57Nerlynx $32.39Talvey $32.24Tecvayli $32.24Cabometyx $30.19Rylaze $29.96Hemgenix $29.85Kimmtrak $29.71Scemblix $29.65Danziten $29.42Mektovi $28.59Xalkori $28.59Braftovi $28.59Besponsa $26.44Kyprolis $25.19Blincyto $25.19Elahere $24.75
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dallin Gambles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.